Announce Date | 04/30/2025 |
EPS Normalized Actual | $-0.16 (Miss by $-0.11) |
EPS GAAP Actual | $-0.16 (Miss by $-0.11) |
Revenue Actual | $0.299943B |
Revenue Surprise | Beat by $299.943M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.67415 |
EPS GAAP Estimate | $1.67415 |
Revenue Estimate | $0.404092372B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0 | INF | 0 | 0 | 2 |
Dec 2027 | 11.16 | 4.55 | 10.90512 | 11.46366 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.16 | -1.90929 | 0.299943B | -67.87% | -67.82M |
FQ4 2024 (Dec 2024) | 0.0217 | 0.0217 | 0.297465B | -22.3% | 297.47M |
FQ3 2024 (Sep 2024) | 0.8 | 0.8 | 0.32772B | -29.22% | 327.72M |
FQ4 2015 (Dec 2015) | 0 | 0 | 0.05765B | 100% | 57.65M |
FQ2 2024 (Jun 2024) | 1.35 | 1.35 | 0.396524B | 4.25% | 396.52M |
FQ1 2024 (Mar 2024) | 2.63 | 2.63 | 0.503512B | -1.22% | 503.51M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0.363804B | 5.24% | 363.8M |
FQ3 2023 (Sep 2023) | 1.64 | 1.64 | 0.423487B | 7.86% | 423.49M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.67415
Consensus Revenue Estimates
0.404092372B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.92985 | -- | 0.86 | 0.99395 | 1 |
FQ2 2027 (Jun 2027) | 0.95561 | -- | 0.88383 | 1.02148 | 1 |
FQ1 2027 (Mar 2027) | 0.98596 | -- | 0.9119 | 1.05393 | 1 |
FQ4 2026 (Oct 2026) | 1.66288 | -- | 1.52954 | 1.80553 | 0 |
FQ3 2026 (Jul 2026) | 1.69789 | -- | 1.56175 | 1.84354 | 0 |
FQ2 2026 (Jun 2026) | 2.1 | -- | 1.95843 | 2.19696 | 0 |
FQ1 2026 (Mar 2026) | 1.96 | 108.16 | 1.82787 | 2.05049 | 0 |
FQ4 2025 (Oct 2025) | 1.67252 | 98.7 | 1.53841 | 1.81599 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.63B | -- | 0.59B | 0.66B | 2 |
FQ2 2027 (Jun 2027) | 0.62B | -- | 0.58B | 0.65B | 2 |
FQ1 2027 (Mar 2027) | 0.6B | -- | 0.57B | 0.64B | 2 |
FQ4 2026 (Oct 2026) | 0.39B | -- | 0.37B | 0.42B | 1 |
FQ3 2026 (Jul 2026) | 0.41B | -- | 0.38B | 0.43B | 1 |
FQ2 2026 (Jun 2026) | 1.27B | -- | 1.21B | 1.32B | 1 |
FQ1 2026 (Mar 2026) | 1.18B | 74.63 | 1.12B | 1.22B | 1 |
FQ4 2025 (Oct 2025) | 0.41B | 27.25 | 0.38B | 0.44B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.74929 | -0.16 | -1.90929 | 1193.31% |
FQ4 2024 (Dec 2024) | 0.0217 | 0.0217 | 100% | |
FQ3 2024 (Sep 2024) | 0.8 | 0.8 | 100% | |
FQ4 2015 (Dec 2015) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 1.35 | 1.35 | 100% | |
FQ1 2024 (Mar 2024) | 2.63 | 2.63 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 1.64 | 1.64 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.37B | $0.3B | $-67.82M | -22.61% |
FQ4 2024 (Dec 2024) | $0B | $0.3B | $297.47M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.33B | $327.72M | 100% |
FQ4 2015 (Dec 2015) | $0B | $0.06B | $57.65M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.4B | $396.52M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.5B | $503.51M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.36B | $363.8M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.42B | $423.49M | 100% |